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ABSTRACT
Objective To evaluate the agreement between
multislice CT (MSCT) and intravascular ultrasound (IVUS)
to assess the in-stent lumen diameters and lumen areas
of left main coronary artery (LMCA) stents.
Design Prospective, observational single centre study.
Setting A single tertiary referral centre.
Patients Consecutive patients with LMCA stenting
excluding patients with atrial ﬁbrillation and chronic
renal failure.
Interventions MSCT and IVUS imaging at
9–12 months follow-up were performed for all patients.
Main outcome measures Agreement between MSCT
and IVUS minimum luminal area (MLA) and minimum
luminal diameter (MLD). A receiver operating
characteristic (ROC) curve was plotted to ﬁnd the MSCT
cut-off point to diagnose binary restenosis equivalent to
6 mm2 by IVUS.
Results 52 patients were analysed. Passing–Bablok
regression analysis obtained a β coefﬁcient of 0.786
(0.586 to 1.071) for MLA and 1.250 (0.936 to 1.667)
for MLD, ruling out proportional bias. The α coefﬁcient
was −3.588 (−8.686 to −0.178) for MLA and −1.713
(−3.583 to −0.257) for MLD, indicating an
underestimation trend of MSCT. The ROC curve identiﬁed
an MLA ≤4.7 mm2 as the best threshold to assess in-
stent restenosis by MSCT.
Conclusions Agreement between MSCT and IVUS to
assess in-stent MLA and MLD for LMCA stenting is
good. An MLA of 4.7 mm2 by MSCT is the best
threshold to assess binary restenosis. MSCT imaging
can be considered in selected patients to assess LMCA
in-stent restenosis.
INTRODUCTION
Multislice CT (MSCT) is an evolving non-invasive
technique able to reconstruct accurately the lumen
contours of coronary arteries.1–5 Although the evalu-
ation of coronary stents is challenging, due to arte-
facts created by the metal of the struts, MSCT has
proven reliable in assessing in-stent restenosis.6–8 The
accuracy of MSCT to assess in-stent restenosis is even
better when large stents (>3 mm nominal diameter)
are investigated.9
Coronary artery bypass grafting (CABG) is con-
sidered to be the recommended treatment for left
main coronary artery (LMCA) stenosis.10 11
However, percutaneous coronary intervention
(PCI) of LMCA stenosis can be considered for
patients with a low SYNTAX score and for patients
who are not suitable for CABG.12–14 Although
routine follow-up invasive coronary angiography in
patients with LMCA stenosis treated with PCI is
under debate, this has been suggested in current
European guidelines to be performed at 3–
12 months follow-up.13 In those patients, intravas-
cular ultrasound (IVUS) allows a more accurate
analysis of the LMCA stent, the assessment of
neointimal hyperplasia, and the assessment of
lumen area and diameter than coronary
angiography.15
Non-invasive imaging techniques such as MSCT
can be helpful to evaluate in-stent restenosis in
patients with LMCA stenting at follow-up.16 17
However, there is a lack of information comparing
the in-stent lumen dimensions between MSCT and
IVUS imaging. Furthermore, the role of MSCT to
assess in-stent restenosis in patients with LMCA
stenting in routine clinical practice is not well
deﬁned.
The aim of the present study is to evaluate the
agreement between MSCT and IVUS to assess the
in-stent lumen diameter and lumen areas of LMCA
stents at follow-up. A secondary end point of the
present study is to deﬁne a cut-off value for MSCT
derived minimum luminal area (MLA) that is able
to predict signiﬁcant in-stent restenosis.
METHODS
This is a prospective, observational single centre
study. Since November 2010 all consecutive
patients with de novo LMCA stenosis treated with
stenting were included in the study. MSCTwas per-
formed in all patients 9–12 months after LMCA
PCI. None of the recruited patients presented with
symptoms previous to the scheduled MSCT.
Coronary angiography and IVUS were performed
within a week of the follow-up MSCT imaging.
Exclusion criteria were chronic renal failure with
creatinine clearance <60 ml/min, previous allergic
reaction to contrast media, contraindication to
β-blocker treatment, and atrial ﬁbrillation or atrial
ﬂutter. All patients provided written informed
consent and the protocol was approved by the local
ethics committee.
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MSCT
Non-invasive coronary angiography was performed with a
64-slice CT scanner (Lightspeed VCT 64-slice GE Medical
Systems, Waukesha, Wisconsin). Patients with a heart rate over
65 beats/min received propranolol (1 mg/ml) intravenously to
reduce their heart rate. A bolus dose of 80 ml of contrast (iodix-
anol, 320 mg of iodine per 1 ml; Visipaque, GE Healthcare UK)
was infused at 5 ml/s and saline solution was infused immedi-
ately after the iodine contrast to reduce hyperattenuation of the
right cavities (20 ml at 5 ml/s). No non-contrast study was previ-
ously performed.
MSCT data were acquired by the ﬂuoroscopic bolus tracking
technique, which was started as soon as the signal density level
in the ascending aorta reached a threshold of 100 Hounsﬁeld
units.
Scan parameters were as follows: a detector collimation width
64×0.625 mm, gantry rotation time 350 ms, 0.2 pitch, and use
of dose modulation (peak tube current of 600 mA during
65–85% of the R-R interval and minimal tube current of
300 mA). For estimation of the effective dose, the product of
the dose–length product and the chest organ weighting factor
(k=0.014 mSv×(mGy×cm)–1 averaged between male and
female models) was calculated.18
Image reconstruction was retrospectively gated to the ECG.
An experienced radiologist and an experienced cardiologist
jointly evaluated the original axial images and multiplanar
reformatted reconstructions. Cross-sectional orthogonal lumen
areas and diameters were measured throughout the entire stent
length and the minimum luminal diameter (MLD) and MLA
were visually determined and assessed. Stent external and
internal diameters including the blooming artefact can be easily
deﬁned along the stent.19 In case there was no evidence of
neointimal proliferation, we measured the internal diameter
with electronic calipers, as some grade of neointimal prolifer-
ation could be hidden by the artefact. When the neointimal pro-
liferation was large enough to overtake the blooming artefact
and be detected by MSCT, the MLD and MLA were measured.
Analyses of MSCT images were performed at a dedicated work-
station (GE Medical Systems, Waukesha, Wisconsin, USA).
A semiquantitative analysis of the MSCT data was also per-
formed. The stent segment, including its proximal and distal
borders, was analysed in detail. In the case of LMCA bifurcation
stenting, each of the three segments (LCMA, left anterior des-
cending, and circumﬂex coronary artery) were evaluated indi-
vidually. The stent was classiﬁed as patent when no
neoproliferation or a non-obstructive neoproliferation was seen;
it was classiﬁed as in-stent restenosis when >50% narrowing of
the lumen diameter was detected. Binary angiographic stenosis
was also assessed at the left anterior descending and left circum-
ﬂex coronary ostia. Stents not assessable by MSCTwere deﬁned
when binary in-stent restenosis could not be ruled out due to
the bad quality of the images; stents not assessable were assigned
as having binary in-stent restenosis.
X-ray coronary angiography
Conventional coronary angiography was performed using stand-
ard techniques after intracoronary injection of 2 mg glyceryl tri-
nitrate (GTN). Two or three orthogonal views were performed,
without foreshortening or side-branch overlap. The same views
were repeated immediately after the procedure and at late
follow-up. Quantitative coronary angiography was performed
by an experienced analyst blinded to the MSCT data with dedi-
cated software (CAAS II system, Pie Medical, Maastrich, The
Netherlands). The MLD, MLA, and binary angiographic
in-stent restenosis rate (>50% diameter stenosis) were assessed
within the in-stent segment.
IVUS
IVUS imaging was performed at follow-up according to standard
procedures. Following the administration of 5000 IU heparin
and 2 mg GTN, the IVUS catheter (Boston Scientiﬁc Atlantis SR
Table 1 Clinical features
Patient demographics (n=52)
Age (years) ±SD 70±11 (39–88)*
Males, n (%) 44 (84.6%)
Risk factors
Hypertension, n (%) 44 (84.6)
Diabetes mellitus, n (%) 22 (42.3)
Hypercholesterolaemia, n (%) 40 (76.9)
Current smoker, n (%) 13 (25.0)
Obesity (BMI >30 kg/m2) 8 (15.4)
Previous cardiological history
Previous CABG, n (%) 7 (13.5)
Previous AMI, n (%) 14 (26.9)
Previous PCI (not in LMCA), n (%) 15 (28.8)
Ejection fraction, %±SD 56±10
*Age range.
AMI, acute myocardial infarction; BMI, body mass index; CABG, coronary artery
bypass graft; LMCA, left main coronary artery; PCI, percutaneous coronary
intervention.
Table 2 Procedural characteristics
LMCA characteristics (n=52)
Protected LMCA 5 (9.6%)
Clinical indication
Stable angina 21 (40.4%)
NSTEMI 27 (51.9%)
STEMI 4 (7.7%)
Stenting technique
Single stent technique 38 (73.1%)
Two stent technique 14 (26.9%)
Stent features (n=66)
Drug eluting stent 66 (100%)
Stent length, mm 17.31±5.23
Stent diameter, mm 3.42±0.42
Implantation pressure, atm 17.85±2.58
LMCA, left main coronary artery; NSTEMI, non-ST segment elevation myocardial
infarction; STEMI, ST segment elevation myocardial infarction.
Table 3 Multislice CT features
n=52
Estimated radiation dose (mSv) 14.10±4.19
kV 118.3±5.8
mA 508.7±28.8
Heart rate 58.4±9.1
Patients treated with β-blockers 26 (50.0%)
Patients not analysable 2 (3.8%)
Data are expressed as mean±SD or count (%).
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2.8F 40 MHz) was positioned at least 10 mm distal to the stent
edge in the left anterior descending artery. IVUS imaging was
recorded during an automatic pullback at 0.5 mm/s. Two experi-
enced observers, blinded to the MSCT imaging, analysed the
IVUS images using quantitative coronary ultrasound by dedicated
software (QCU-CMS, MEDIS, Leiden, The Netherlands). This
system performs a previous contour correction for cardiac
motion artefacts using a combination of transversal and longitu-
dinal contour detection techniques that allow accurate two and
three dimensional analysis.20 MLA, mean stent area, MLD, mean
stent diameter, and maximal neointimal hyperplasia (mm) were
estimated within the stent segment.
Statistics
Continuous normally distributed variables were presented as
mean ±SD, and non-normally distributed variables were
presented as median and IQR. Categorical variables were pre-
sented as counts and percentages. Continuous variables were
compared by Student’s t test when variables were normally dis-
tributed and by Mann–Whitney U test when variables were non-
normally distributed. All tests were two-tailed, and a p value of
0.05 was considered signiﬁcant. Categorical variables were com-
pared by χ2 test. All statistical analyses were performed with
PASW statistics 18.0 (SPSS Inc, Chicago Illinois, USA).
Agreement analysis between MSCT and IVUS imaging was
performed using the Passing–Bablok regression analysis and
Bland–Altman plots. In brief, Passing–Bablok regression analysis
obtains an α and β coefﬁcient. The α coefﬁcient assesses the sys-
tematic bias: a conﬁdence interval (CI) below zero denotes a
constant underestimation trend whereas values over zero denote
an overestimation trend. The β coefﬁcient assesses the propor-
tional bias: a good agreement is present when its CI includes
1.21 Bland–Altman analysis reveals the delta between both tech-
niques and its CI. Furthermore, consistency and absolute inter-
class correlation coefﬁcients (ICC) were obtained in order to
further discern possible additive or proportional differences. An
ICC <0.4 indicates bad agreement, an ICC between 0.4 and
0.75 indicates moderate agreement, and ICC values >0.75 indi-
cate excellent agreement.22 Agreement between binary variables
was measured with the κ index.
Test accuracy (percentage of patients correctly classiﬁed), sen-
sitivity, speciﬁcity, and positive and negative predictive values of
Table 4 Measures of left main coronary artery stents
QCA MSCT IVUS
MLD (mm) 2.84±0.57 2.70±0.68 3.04±0.54
MLA (mm2) 6.59±2.69 5.59±2.09 7.23±2.79
IVUS, intravascular ultrasound; MLA, minimum luminal area; MLD, minimum luminal
diameter; MSCT, multislice CT; QCA, quantitative coronary angiography.
Figure 1 Passing–Bablok regression results. (A) Agreement between multislice CT (MSCT) and intravascular ultrasound (IVUS) minimum luminal
diameter (MLD). (B) Agreement between MSCT and IVUS minimum luminal area (MLA). (C) Agreement between MSCT and quantitative coronary
angiography (QCA) MLD.
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MSCT for the detection of in-stent restenosis compared to
quantitative coronary angiography were calculated on a per
patient basis. A receiver operating characteristic (ROC) curve
was plotted in order to ﬁnd the cut-off point of MLA assessed
by MSCT to identify in-stent restenosis better, using as gold
standard an MLA of 6 mm2 determined by IVUS, which is a
recently validated clinically signiﬁcant MLA for LMCA
lesions.23
RESULTS
Seventy-two patients with previous PCI of LMCA were
screened. A total of 52 patients met the inclusion criteria and
were prospectively included. Eight patients were excluded
because of atrial ﬁbrillation, 10 patients due to chronic renal
failure, and two patients because they withdrew consent. An
MSCT study was performed at a median follow-up of 331 days
(IQR 295–386 days) after PCI of LMCA. All but one underwent
coronary angiography at a median of 7 days after MSCT. This
patient withdrew consent after undergoing MSCT and was also
excluded from the study. After MSCTexamination IVUS images
could not be obtained in four patients because of failure to pro-
gress the IVUS catheter through the stent (severe stenosis, angu-
lated anatomy or stent protrusion into the aorta). These patients
were excluded from quantitative analysis.
Patient demographics and procedural ﬁndings are summarised
in tables 1 and 2, respectively. More than 70% of the patients
were treated with a single stent technique and the mean stent
diameter was 3.42 mm, permitting a correct evaluation of stent
patency with MSCT (table 2). MSCT characteristics are shown
in table 3. Two patients could not be assessed because of severe
vascular calciﬁcation and movement artefacts resulting from an
inability to maintain prolonged apnoea. Both were classiﬁed as
presenting in-stent restenosis. No procedure complications
developed in any of those cases. Table 4 shows LMCA stent
measurements by quantitative coronary angiography, MSCT,
and IVUS. Agreement analysis for MLD and MLA is shown in
ﬁgure 1. Bland–Altman plots for the MLA and MLD values
between MSCT and IVUS are shown in ﬁgure 2A and B and
revealed a good agreement for both MLD and MLA; however,
the derived MSCT, MLD, and MLA values presented with an
underestimation trend of 0.4 mm and 2 mm2 with respect to
IVUS derived parameters. Bland–Altman plots also showed
good agreement between MSCT and quantitative coronary angi-
ography for MLD (ﬁgure 2C).
Agreement between MSCT and IVUS measured by consist-
ency ICC was excellent both for MLD (0.826, 95% CI 0.681 to
0.905) and MLA (0.823, 95% CI 0.675 to 0.903), whereas
absolute ICC was moderate for MLD (0.717, 95% CI 0.084 to
0.886) and MLA (0.666, 95% CI 0.143 to 0.874). Agreement
between quantitative coronary angiography and MSCT derived
MLD was good both for consistency and absolute ICC: 0.792
(95% CI 0.661 to 0.889) and 0.753 (95% CI 0.478 to 0.876),
respectively.
On coronary angiography, 14% of patients presented with
binary in-stent restenosis. MSCT accuracy to predict angio-
graphic binary in-stent restenosis was 88% (95% CI 58.0% to
97.3%), with a sensitivity of 90% (95% CI 59.6% to 98.2%), a
speciﬁcity of 90% (95% CI 78.0% to 96.0%), a positive predict-
ive value of 69.2% (95% CI 38.9% to 89.6%), a negative pre-
dictive value of 97.3% (95% CI 84.2% to 99.8%), and a κ
index of 0.719. There was one false negative case; this patient
was treated with a T stent technique and presented with side
branch restenosis. There were four false positive cases, all of
them with a complex two stent technique.
Figure 2 Agreement analysis using Bland–Altman regression between
multislice CT (MSCT), intravascular ultrasound (IVUS), and quantitative
coronary angiography (QCA). (A) Comparison of MSCT and IVUS
minimum luminal diameter (MLD). (B) Comparison of MSCT and IVUS
minimum luminal area (MLA). (C) Comparison of MSCT and QCA MLD.
Figure 3 Receiver operating characteristic (ROC) curve for minimum
luminal area assessed by multislice CT for detection of signiﬁcant
restenosis deﬁned as minimum luminal area <6 mm2 assessed by
intravascular ultrasound. An area under the curve of 0.811 was
obtained with a cut-off point of 4.7 mm2.
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On IVUS, 15% of patients presented with in-stent restenosis
(MLA ≤6 mm2). The ROC curve, with the cut-off point that
best deﬁnes signiﬁcant restenosis by MLA assessed by MSCT, is
plotted in ﬁgure 3. An area under the curve of 0.811 (95% CI
0.673 to 0.950) was obtained, showing that an MLA <4.7 mm2
was able to detect signiﬁcant restenosis with a sensitivity of
87%, a speciﬁcity of 62%, a positive predictive value of 66%,
and a negative predictive value of 94%. Figures 4 and 5 show
examples of the correlation of MSCTand IVUS images.
DISCUSSION
The main results of the present study are: (1) agreement
between quantitative angiography, MSCT and IVUS is good
when assessing LMCA in-stent MLD and MLA; (2) MSCT sys-
tematically underestimates the LMCA in-stent MLD and MLA
compared to IVUS; (3) the MSCT derived MLA cut-off value of
4.7 mm2 seems to be the most appropriate threshold to assess
stent patency at 12 months follow-up.
Sixty-four row CT allows a spatial resolution of 350–400 mm,
while previous CT generations had a signiﬁcantly lower reso-
lution. IVUS catheters allow a spatial resolution of around 100–
150 mm. For this reason, current guidelines suggest that non-
invasive study of stents should be performed with at least a 64
channel MSCT.24 Previous studies evaluating LMCA stent
patency with MSCT were performed with 16 row CT and a
combination of 16 and 64 row CT.16 17 This study is the ﬁrst to
analyse LMCA stents with a 64 row MSCT.
The present study shows an underestimation trend of MSCT for
in-stent measures quantiﬁed around 0.4 mm in MLD and around
2 mm2 in MLA compared to IVUS. The underestimation trend of
MSCT could be explained by the blooming artefact of metallic
struts. Metallic struts hamper detection of the lumen contour and
may partially hide the neointimal tissue between the artefact. A
previous publication comparing in-stent measures between MSCT
and IVUS found that MSCTwas able to detect neointimal hyper-
plasia >1 mm.16 Below 1 mm the blooming artefact did not allow
an appropriate measurement. In addition, a good agreement
between quantitative coronary angiography and MSCT measure-
ments was observed (with a slight non-signiﬁcant underestimation
trend), a point that strengthens our results and supports MSCTas
a good non-invasive technique for LMCA stent examinations.
Furthermore, we found a cut-off point of 4.7 mm2 on MSCT
derived MLA to assess in-stent restenosis. This cut-off has been
correlated with the 6 mm2 threshold assessed by IVUS.
It is important to note that ﬂow fractional reserve could have
been a good standard to compare with; however, we have per-
formed the comparison with IVUS due to recent growing evi-
dence in regard to this scenario.23
A recently published study23 has clinically validated this IVUS
derived MLA in LMCA, showing that patients with an MLA above
this point have an excellent clinical prognosis. Moreover, the
6 mm2 value was obtained from Murray’s law (considering an
MLA of 4 mm2 as the ischaemic threshold of the branches),23 and
has been supported by a study that used IVUS and pressure wire
Figure 4 (A) Multislice CT (MSCT) image of a patent stent in the left main coronary artery with no in-stent restenosis. (B) Cross-section MSCT
image. (C) Cross-section intravascular ultrasound (IVUS) image. (D) Longitudinal IVUS image of the same patent stent.
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ﬂow fractional reserve.25 The difference between 4.7 mm2 and
6 mm2 is explained by the underestimation produced by the
blooming artefact, which is also reﬂected by the modest absolute
ICC obtained between these two techniques. Therefore, the
MSCTcut-off may have important clinical implications.
Patients with LMCA stenosis treated with a single stent tech-
nique, without severe coronary artery calciﬁcation and nominal
stent diameter >3 mm, are suitable for a non-invasive follow-up
to rule out in-stent restenosis. In those patients it is reasonable to
use the 4.7 mm2 threshold for a non-invasive follow-up, avoiding
the invasive test suggested by the current guidelines.13
The usefulness of non-invasive testing for the evaluation of
LMCA stenosis treated with a double stent technique is still
uncertain; therefore, this technique cannot be recommended as
routine practice in this setting. The double layer of struts pro-
duces an excessive metallic artefact that does not allow for a
proper analysis of the lumen. In fact, we report three false posi-
tive cases and no false negative cases. It is remarkable that all
misclassiﬁed cases were patients treated with complex double
stent techniques (Crush stent technique and T stent technique).
All patients treated with one stent were correctly diagnosed.
Study limitations
The ﬁrst limitation of the present study is the low incidence of
in-stent restenosis, which may have an important inﬂuence on
the relatively low positive predictive value.
The second limitation is the exclusion criteria. Patients with
atrial ﬁbrillation, which is not a rare phenomenon in individuals
with cardiac disease, were excluded from this study, thus pre-
venting conclusions to be drawn about an important group of
patients who may beneﬁt from this technique in the future.
Finally, it is well known that different types of stents have dif-
ferent blooming artefacts by MSCT.19 The present study used
different types of metallic platforms, strut thickness and alloys;
therefore, the suggested cut-off to assess in-stent restenosis by
MSCT may slightly change according to the stent type.
CONCLUSIONS
MSCT is an adequate technique to analyse LMCA stents,
showing a good correlation with IVUS, albeit with an underesti-
mation trend due to blooming artefacts observed with MSCT.
The present study supports a cut-off of 4.7 mm2 MLA, as
assessed by MSCT, which provides an appropriate threshold for
the diagnosis of LMCA in-stent restenosis. Non-invasive MSCT
imaging can be considered in selected patients with an LMCA
stent to assess in-stent restenosis, instead of an invasive imaging
technique.
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Figure 5 (A) Multislice CT (MSCT) image of a left main coronary artery stent with in-stent restenosis. (B) Cross-section MSCT image.
(C) Cross-section intravascular ultrasound (IVUS) image. (D) Longitudinal IVUS image of the same stent.
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